Protein engineering and designing novel enzymes and proteins

Protein engineering and designing novel enzymes and proteins for

biotechnological applications

Introduction

Proteins represent the fundamental molecular workhorses carrying out diverse functions

essential to life. While evolution naturally optimizes protein functions adapted to biological

roles, human ingenuity through protein engineering now aims to design novel biomolecules

tailored for industrial and therapeutic purposes. By rationally mutating amino acid sequences,

protein engineers create proteins with properties evolution did not select for such as enhanced

catalysis, altered substrate specificities, and unique functional capabilities opening new

frontiers across biotechnology, medicine and green chemistry.

The ability to engineer proteins enabling new biochemical syntheses and reactivity profiles

represents a powerful paradigm embracing sustainability and precision through nature-

inspired design. Already, protein engineering revolutionizes fields as diverse as drug

discovery, consumer goods manufacturing, bioenergy, bioremediation and more through

tailored biocatalysts. Advanced technologies now accelerate computational protein design

promising even more transformative applications. However, technical challenges remain

optimizing protein folding, stability and functional expression. Evolving sustainable practices

also mitigates risks from uncontrolled synthetic biology.

This review surveys major protein engineering methodologies, their applications expanding

industrial biocatalysis and therapeutic protein development, as well as future directions and

responsibilities ensuring responsible innovation through human oversight of emergent

synthetic life. While technical obstacles persist, the rapidly growing impact of tailor-made

proteins synthesized de novo or evolved in vitro show vast potential responsibly realizing

sustainable human prosperity through controlled reprogramming of natural biochemical

foundations.

Protein Engineering Methodologies

Designing novel protein structures and functions first demands versatile engineering

strategies:

Rational Design

Computational protein modeling tools predictively mutate sequences to establish structure-

function relationships, optimize desired activities and introduce new capabilities. Techniques

include homology modeling, binding energy calculations and molecular dynamics

simulations guiding targeted substitutions, insertions or deletions of amino acids along

enzymatic active sites or protein interfaces.

Directed Evolution

Iteratively applying random mutagenesis combined with selection for improved properties

evolves proteins in vivo or in vitro beyond natural constraints. Methods such as error-prone

PCR, DNA shuffling, CASTing and phage/Yeast display have evolved antibodies, enzymes

and molecular scaffolds far surpassing starting activities through Darwinian mechanisms.

Combinatorial Approaches

Methods enable large libraries screening vast protein sequence and structure spaces. DNA-

encoded libraries genetically link phenotype to genotype through physical links or barcoded

tagging which facilitates function-driven selection or screening of billions of protein variants

simultaneously in vitro or in vivo.

Computational Design & Directed Evolution Combinations

Converging rational design with directed evolution accelerates novel protein discovery. In

silico predictions guide libraries toward optimized regions which directed evolution then

further exploits, iteratively promoting synergistic computational and experimental

optimization. Combined approaches revolutionize protein engineering timelines.

Overall, advances allowing precise, large-scale and automated protein manipulations power

new waves of economically transformative and medically revolutionary applications

leveraging natural biochemical diversity and catalysts at an accelerated pace.

Protein Design Tools and Techniques

Protein engineers apply multidisciplinary methods tailoring protein behaviors:

Computational Modeling

Molecular modeling simulates protein folding, stability, binding interactions and catalytic

mechanisms to rationally guide designs toward optimized structures and functions.

Techniques include homology modeling, docking, molecular dynamics, Free Energy

Perturbation calculations and quantum mechanics/molecular mechanics (QM/MM).

Protein Manipulation

Site-directed and cassette mutagenesis, domain insertion/deletion, circular permutation enable

tailored recombination and mutagenesis within structural domains. Isosteric replacements

substitute amino acids with similar volumes/properties to fine-tune engineered proteins.

Protein Expression Systems

Bacteria, yeast, mammalian and plant expression systems produce libraries at industrial

scales facilitating high-throughput assays. Cell-free and synthetic biology techniques also

produce proteins de novo. Protein misfolding correcting chaperones aid heterologous

expression of intricate structures.

Protein Analysis and Screening

High-throughput assays evaluate libraries analyzing millions of variants through

fluorescence-activated cell sorting, ELISA, mass spectrometry, DNA or protein microarrays

matching phenotypes to genotypes for optimization.

Put together, these multidisciplinary tools leverage scientific convergences across

computation, synthetic biology and bioengineering towards realizing both conceptual and

applied innovations through protein engineering's growing impact on industry and medicine.

Biotechnological and Industrial Applications

Protein engineering already industrializes diverse applications through thermostable and

regio/enantioselective biocatalysts ideally suited for renewable and environmentally friendly

manufacturing:

Fine Chemical Production

Tailored hydrolases, lyases, isomerases, oxidoreductases and transferases perform regio- and

stereoselective enzymatic syntheses forming bio-based pharmaceuticals, agrochemicals,

food-additives and commodity chemicals sustainably under mild conditions. Engineered

enzymes now produce over 150 commercially important chemicals.

Bulk Chemical Production

Thermophilic esterases, lipases and transaminases improve productivity at extreme industrial

temperatures and pH ranges. Stable yet low-cost engineered enzymes also hydrolyze

polymers and macromolecules through biocatalytic upcycling converting waste biomolecules

into higher value biofuels, plastics and chemicals.

Bioprocessing

Amylases, proteases, biosurfactants and biosensors improve yield, efficiency and

sustainability across food, detergent, textile and leather industries. Engineered switchable

enzymes and smart responsive biocatalysts coupled to biosensors offer online process

monitoring and control over industrial bioprocesses.

Biopolymer Production

Microbial cell factories metabolically engineered through synthetic biology express non-

native pathways producing renewable bioplastics, biofuels, biodegradable materials and

specialty chemicals leveraging plant biomass as sustainable feedstocks.

Bioremediation and Biomining

Tailored organophosphorus hydrolases, heavy metal sequestering phytases and laccases

naturally or artificially selected enable ecofriendly bioremediation and mining operations

extracting valuables from waste streams and contaminated soils through enzymatic

transformations under ambient conditions.

Protein engineering thus revolutionizes industrial biotechnology through sustainable and

precision-controlled green chemistry, biomanufacturing tailored microbes and eco-friendly

catalytic processes disrupting traditional fossil fuel-dependent industries. Multiplying these

impacts depends on expediting discovery through exponentially growing computational

capabilities.

Therapeutic Protein Development

Protein engineering further impacts medicine through designer therapeutics addressing key

challenges in vaccination, enzyme replacement therapies and antibody development. Notable

applications include:

Vaccine Development

Rational design stabilizes immunogenic epitopes through directed mutagenesis allowing

oral/nasal delivery of subunit vaccines without adjuvants or cold-chain requirements.

Engineered antigens enable rapid responses against emerging infectious diseases and

pathogens resistant to traditional vaccines.

Enzyme Replacement Therapies

Modification of therapeutic enzymes’ pharmacokinetic profiles, solubility, stability, activity,

targeting or lysosomal compartmentalization overcomes challenges in Gaucher’s, Pompe’s,

Fabry’s and other diseases treated through recombinant proteins administered exogenously.

Monoclonal Antibody Therapies

Computational protein design coupled with directed evolution or in silico affinity maturation

rapidly optimizes binding affinities and specificities of antibody fragments, Fc-domains or

scaffolds toward therapeutic macromolecular targets against cancers and

autoimmune/inflammatory disorders with minimal off-target effects.

Cell and Gene Therapies

Synthetic biology recodes and optimizes viral vectors, engineered T-cell receptors, chimeric

antigen receptors and gene editing/base editing systems targeting disease-associated genomic

sequences or cell surface receptors with high precision and minimal immunogenicity.

Overall, continuous innovations in computational protein modeling, large library screening

and heterologous expression systems empower researchers designing novel therapeutic

proteins against previously intractable disease targets with optimized safety, stability and

efficacy profiles.

Challenges and Opportunities

Despite exponential advances, opportunities to expand industrial and therapeutic capabilities

through protein engineering remain constrained by several technical challenges:

Protein Folding and Conformational Stability

Predicting and stabilizing complex tertiary structures against thermal/chemical denaturation

remains a major hurdle slowing enzyme robustness and functional expression. Advances in

AI-guided molecular simulations continue closing gaps in reliably modeling intricate folding

kinetics.

Balancing Activity and Stability Trade-offs

Optimizing catalytic properties often comes at the expense of stability and vice versa.

Improved multi-objective optimization techniques balancing these tradeoffs through

computational steering facilitate commercially viable biocatalyst development.

Heterologous Expression Bottlenecks

Reliably producing intricate multi-domain proteins, especially in larger scale processes,

proves difficult for non-native hosts. Advances in synthetic biology, cell-free expression and

membrane engineering address bottlenecks limiting libraries examined.

Limited Catalytic Repertoire

Expanding the scope of chemistries amenable to enzymatic catalysis opens new reaction

spaces and broadens biomanufacturing possibilities. Combining computational design with

high-throughput experimentation through DNA-encoded library screening accelerates

discovery.

Intellectual Property Management

Strengthening global standards encourages sharing models, datasets and tools through

transparent IP policies balancing open innovation with commercial incentives sustaining the

biotechnology industry.

Sociotechnical Responsibilities

Prudent regulation, oversight and education balance scientific opportunities against

responsibilities ensuring control, safety and equitable access as protean synthetic life blurs

natural/artificial boundaries through exponential gains across disciplines including materials

engineering, nanotechnology and artificial intelligence.

By systematically addressing persisting scientific and ethical responsibilities through prudent

international coordination, protein engineering promises sustainability, precision and disease

control through harnessing biology's foundational molecular programs rationally optimized

for worldwide prosperity and resilience.

Future Directions

Continual progress depends upon cultivating scientific excellence and responsible innovation

through converging disciplines:

Computational Protein Design

Machine learning, physical simulation capabilities and expanding structure databases promise

predictive full chain protein design from sequence to quaternary structure for catalytic and

materials applications.

Directed Evolution Acceleration

Automated platforms rapidly evolving entire metabolic pathways through modular genetic

parts fabrication and high-throughput screening enable agile responses against emergent

threats.

Multi-Omics Integration

Combining genomics, epigenomics, proteomics, metabolomics and phenomics data through

artificial intelligence guides comprehensive protein and pathway engineering optimizing

complex traits precisely at multiscale levels from organs to communities.

Synthetic Biology Standardization

Open access registries, sequence repositories, genetic parts kits and modular assembly

standards accelerate applications across therapeutics, biomanufacturing, environmental

monitoring through portability and replicability ensuring responsible development.

Convergent Technologies

Materials science, nanotechnology, automation, AI/robotics, and instrumentation

convergence empower global-scale programs sustainably addressing challenges in nutrition,

energy, climate through precision control of biological processes at all organization levels.

With continued exponential gains across converging disciplines fueling ever more

transformative applications, the dawn of a new era designing and optimizing life at its most

fundamental molecular levels arrives. However, benefits depend upon mitigating risks

through universal precepts for transparent interdisciplinary coordination ensuring long-term

stability, equity and shared prosperity.